Хлебные крошки
- Главная
-
Аналитика
-
Акции
Акции внутренные
Cyclo Therapeutics, Inc. CYTH
$1.19
+$0.01 (1.02%)
На 18:04, 12 мая 2023
Ранг: 3
Ключевые показатели
-
Marketcap
13088442.00000000
-
week52high
2.75
-
week52low
0.67
-
Revenue
1375760
-
P/E TTM
0
-
Beta
-0.41868500
-
EPS
-2.58000000
-
Last Dividend
0.00000000
-
Next Earnings Date
11 мая 2023 г. в 04:00
Описание компании
Cyclo Therapeutics, Inc., a clinical stage biotechnology company, develops cyclodextrin-based products for the treatment of various diseases. Its lead drug candidate is Trappsol Cyclo, an orphan drug, which is Phase III clinical trials for the treatment of Niemann-Pick Type C disease. The company also develops Trappsol Cyclo for the treatment of Alzheimer's disease. In addition, it sells cyclodextrins and related products to the pharmaceutical, nutritional, and other industries, primarily for use in diagnostics and specialty drugs. The company was formerly known as CTD Holdings, Inc. and changed its name to Cyclo Therapeutics, Inc. in September 2019. Cyclo Therapeutics, Inc. was incorporated in 1990 and is based in Gainesville, Florida.
Рекомендации
аналитиков
Рекомендации аналитиков
| Grading company | New grade | Previous grade | Recommendation date |
|---|---|---|---|
| Maxim Group | Buy | 17 дек 2020 г. |
Свежие комментарии
Свежие комментарии
Оставьте свой голос
Оставьте свой голос
Анонимное голосование
Будет ли рост российского рынка к концу года?
-
Да
87% -
Нет
12%
Проголосовал 8 человек
Новостная лента
компании
Insider Summary
Insider Summary
| Reporting Name | Acquistion/Disposition | Owned | Transacted | Transaction Date |
|---|---|---|---|---|
| Toig Randall M. | A | 56722 | 5097 | 08 ноя 2022 г. |
| Sieger Markus | A | 101170 | 9496 | 08 ноя 2022 г. |
| Ostronic Francis Patrick | A | 162490 | 11803 | 08 ноя 2022 г. |
| Ostronic Francis Patrick | A | 150687 | 5000 | 21 сент 2022 г. |
| Ostronic Francis Patrick | A | 91674 | 5762 | 02 авг 2022 г. |
| Sieger Markus | A | 91674 | 5762 | 02 авг 2022 г. |
| Toig Randall M. | A | 51625 | 3093 | 02 авг 2022 г. |
| Ostronic Francis Patrick | A | 138525 | 4988 | 20 мая 2022 г. |
| Ostronic Francis Patrick | A | 133537 | 12 | 20 мая 2022 г. |
| TATE JEFFREY | A | 32160 | 3000 | 16 мая 2022 г. |
Новостная лента
Cyclo Therapeutics to Present at the Virtual Investor 2023 Companies to Watch Event
Business Wire
10 янв 2023 г. в 08:05
GAINESVILLE, Fla.--( BUSINESS WIRE )--Cyclo Therapeutics, Inc. (Nasdaq: CYTH) (“Cyclo Therapeutics” or the “Company”), a clinical stage biotechnology company dedicated to developing life-changing medicines through science and innovation for patients and families living with diseases, today announced that N. Scott Fine, Chief Executive Officer of Cyclo Therapeutics will present at the Virtual Investor 2023 Companies to Watch Event on Thursday, January 19, 2023 at 11:00 AM ET.
Cyclo Therapeutics to Present at the H.C. Wainwright 24th Annual Global Investment Conference
Business Wire
07 сент 2022 г. в 08:05
GAINESVILLE, Fla.--(BUSINESS WIRE)--Cyclo Therapeutics, Inc. (Nasdaq: CYTH) (“Cyclo Therapeutics” or the “Company”), a clinical stage biotechnology company dedicated to developing life-changing medicines through science and innovation for patients and families living with diseases, today announced that N. Scott Fine, Chief Executive Officer of Cyclo Therapeutics will present at the H.C. Wainwright 24th Annual Global Investment Conference being held in New York, NY and virtually on September 12-
Cyclo Therapeutics to Present at the China NPC Association Meeting
Business Wire
08 авг 2022 г. в 08:05
GAINESVILLE, Fla.--(BUSINESS WIRE)--Cyclo Therapeutics, Inc. (Nasdaq: CYTH) (“Cyclo Therapeutics” or the “Company”), a clinical stage biotechnology company dedicated to developing life-changing medicines through science and innovation for patients and families living with diseases, today announced that Lise Kjems, MD, PhD, Chief Medical Officer of Cyclo Therapeutics will present at the 2022 China Nieman Pick Medical Exchange & Sixth Patient Association being held August 13, 2022 in Xiamen,
Cyclo Therapeutics to Present at the NNPDF-INPDA Conferences 2022
Business Wire
21 июл 2022 г. в 08:05
GAINESVILLE, Fla.--(BUSINESS WIRE)--Cyclo Therapeutics, Inc. (Nasdaq: CYTH) (“Cyclo Therapeutics” or the “Company”), a clinical stage biotechnology company dedicated to developing life-changing medicines through science and innovation for patients and families living with diseases, today announced that it will participate at the 30th Annual NNPDF Family Support & Medical Conference in conjunction with the INPDA Biennial Meeting being held July 28-31, 2022, in Orlando, FL. “Perspectives from
Cyclo Therapeutics to Present at the World Orphan Drug Congress USA 2022
Business Wire
11 июл 2022 г. в 08:05
GAINESVILLE, Fla.--(BUSINESS WIRE)--Cyclo Therapeutics, Inc. (Nasdaq: CYTH) (“Cyclo Therapeutics” or the “Company”), a clinical stage biotechnology company dedicated to developing life-changing medicines through science and innovation for patients and families living with diseases, today announced that Lise Kjems, MD, PhD, Chief Medical Officer of Cyclo Therapeutics will present at the World Orphan Drug Congress USA 2022 being held July 11-13, 2022 in Boston, MA. During the session, Dr. Kjems w